“Beyond PD-1/PD-L1: TME-Targeted Therapies in the Era of Immunotherapy Resistance” (2026) Journal of Biomolecules, Pathogenesis and Therapeutics, 2(1), pp. 1–3. Available at: https://jbptjournal.org/index.php/jbpt/article/view/33 (Accessed: 2 June 2026).